Semaglutide is an FDA-approved drug for weight loss in qualified adults
Acknowledgements We would like to thank Jatinder Dhillon and the MedImmune Biologics Expression and Early Expression and Supply teams for generating the peptide-antibody fusions, Sarah Will and Arthur Suckow (MedImmune LLC, Gaithersburg, MD, USA), Dominic Corkill (MedImmune Ltd, Cambridge, UK), Michael Feigh (Gubra, Horsholm, Denmark), the MedImmune and AstraZeneca in vivo science teams for assistance in the design and conduct of rodent studies, Joerg Bluemel (MedImmune LLC, Gaithersburg, MD, USA) for supervising the non-human primate study as well as Nicholas Bhagroo (MedImmune LLC, Gaithersburg, MD, USA) for performing the in vitro glucose-stimulated insulin secretion assay
Diagnostic Methods Diagnosis typically involves measuring plasma carnitine levels and identifying mutations in the relevant genes through genetic testing
Experimental methods Chemicals and reagents High-performance liquid chromatography-grade methanol, water, and acetonitrile were purchased from J.T